Cancer treatment outcome prediction by assessing temporal change: application to cervical cancer

In this paper a novel framework is proposed for the classification of cervical tumors as susceptible or resistant to radiation therapy. The classification is based on both small- and large-scale temporal changes in the tumors' magnetic resonance imaging (MRI) response. The dataset consists of 11 patients who underwent radiation therapy for advanced cervical cancer. Each patient had dynamic contrast-enhanced (DCE)-MRI studies before treatment and early into treatment, approximately 2 weeks apart. For each study, a T1-weighted scan was performed before injection of contrast agent and again 75 seconds after injection. Using the two studies and the two series from each study, a set of tumor region of interest (ROI) features were calculated. These features were then exhaustively searched for the most separable set of three features based on a treatment outcome of local control or local recurrence. The dimensionality of the three-feature set was then reduced to two dimensions using principal components analysis (PCA). Finally, the classification performance was tested using three different classification procedures: support vector machines (SVM), linear discriminant analysis (LDA), and k-nearest neighbor (KNN). The most discriminatory features were those of volume, standard deviation, skewness, kurtosis, and fractal dimension. Combinations of these features resulted in 100% classification accuracy using each of the three classifiers.

[1]  J C Ehrhardt,et al.  Usefulness of tumor volumetry by magnetic resonance imaging in assessing response to radiation therapy in carcinoma of the uterine cervix. , 1996, International journal of radiation oncology, biology, physics.

[2]  G Brix,et al.  Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival. , 1998, Cancer research.

[3]  David L Buckley,et al.  Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix. , 2002, International journal of radiation oncology, biology, physics.

[4]  J C Ehrhardt,et al.  Tumor size evaluated by pelvic examination compared with 3-D quantitative analysis in the prediction of outcome for cervical cancer. , 1997, International journal of radiation oncology, biology, physics.

[5]  J C Ehrhardt,et al.  Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new noninvasive predictive assay. , 1996, International journal of radiation oncology, biology, physics.

[6]  R. Panta Treatment planning in Radiation Oncology , 2010, Journal of Cancer Research and Therapeutics.

[7]  D. Saslow,et al.  The epidemiology of cervical cancer. , 2003, Cancer journal.

[8]  Heinz-Otto Peitgen,et al.  The science of fractal images , 2011 .

[9]  H Okamura,et al.  Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy. , 2000, Radiology.

[10]  M. Knopp,et al.  Cervical carcinoma: comparison of standard and pharmacokinetic MR imaging. , 1996, Radiology.